LEADER 01276nam  2200385Ia 450 
001 9910697071203321
005 20230902162117.0
035   $a(CKB)5470000002384188
035   $a(OCoLC)605908108
035   $a(EXLCZ)995470000002384188
100   $a20100409d2007      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $eacute bacterial sinusitis, developing drugs for treatment
205   $aRev. 1.
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,$d[2007]
215   $a1 online resource (20 pages)
300   $a"Clinical antimicrobial."
300   $a"Draft guidance."
300   $a"October 2007."
517   $aGuidance for industry 
606   $aSinusitis$xTreatment$zUnited States
606   $aDrug development$zUnited States
615  0$aSinusitis$xTreatment
615  0$aDrug development
712 02$aCenter for Drug Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910697071203321
996   $aGuidance for industry$93434577
997   $aUNINA